http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#Head http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#assertion http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#provenance http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#pubinfo http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#assertion http://purl.obolibrary.org/obo/DOID_1558 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1558 http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB09477 http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association http://www.w3.org/2000/01/rdf-schema#label "Enalapril maleate tablets, USP are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. Do not coadminister aliskiren with enalapril maleate in patients with diabetes (see PRECAUTIONS, Drug Interactions Enalapril maleate tablets, USP are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer enalapril maleate tablets USP within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS , Head and Neck Angioedema" http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB09477 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#provenance http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#pubinfo http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#sig http://purl.org/nanopub/x/hasSignature jSxYdPNk9KveT6MUZZSPseCXWsZW4wA7YwwlmjuyolONi1Gy3RxTg7jOA055OdQSpAIHdkAFkBpS1d8KiyRrzz8sG3EFQQ57ikAJ3vILvwalvP/4kWp6Limo6xtxL1Et8nZ8LI6+OsTlN0Hp/ybNgfp5M+FfAO33hBqUcG4ysCc= http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://purl.org/dc/terms/created 2021-08-23T12:30:33.199+02:00 http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAWpmGqxtP3jLnxD14ka6emVYbiTFOJn3gUT7ZSVpJkQE https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY